Simeprevir plus sofosbuvir, with or without ribavirin, to treat chronic infection with hepatitis C virus genotype 1 in non-responders to pegylated interferon and ribavirin and treatment-naive patients: the COSMOS randomised study

@article{Lawitz2014SimeprevirPS,
  title={Simeprevir plus sofosbuvir, with or without ribavirin, to treat chronic infection with hepatitis C virus genotype 1 in non-responders to pegylated interferon and ribavirin and treatment-naive patients: the COSMOS randomised study},
  author={Eric Lawitz and Mark S Sulkowski and Reem H Ghalib and Maribel Rodr{\'i}guez-Torres and Ira M. Jacobson},
  journal={The Lancet},
  year={2014},
  volume={384},
  pages={1756-1765}
}
BACKGROUND Interferon-free regimens are needed to treat hepatitis C virus (HCV) infections. We investigated the efficacy of combined simeprevir and sofosbuvir. METHODS We enrolled patients with chronic HCV genotype 1 infections who had previously not responded to pegylated interferon (peginterferon) and ribavirin or were treatment naive. Patients were randomly assigned in a 2:1:2:1 ratio to receive 150 mg simeprevir and 400 mg sofosbuvir daily for 24 weeks with (group 1) or without (group 2… CONTINUE READING
BETA

Citations

Publications citing this paper.
SHOWING 1-10 OF 394 CITATIONS, ESTIMATED 37% COVERAGE

Safety, Tolerability, and Associated Side Effects of Direct- Acting Antivirals

VIEW 6 EXCERPTS
CITES METHODS & BACKGROUND
HIGHLY INFLUENCED

Hepatic Decompensation Likely Attributable to Simeprevir in Patients with Advanced Cirrhosis

  • Digestive Diseases and Sciences
  • 2014
VIEW 13 EXCERPTS
CITES BACKGROUND & RESULTS
HIGHLY INFLUENCED

Current therapy for chronic hepatitis C: The role of direct-acting antivirals.

  • Antiviral research
  • 2017
VIEW 17 EXCERPTS
CITES METHODS & BACKGROUND
HIGHLY INFLUENCED

Lower response to simeprevir and sofosbuvir in HCV genotype 1 in routine practice compared with clinical trials

  • BMJ open gastroenterology
  • 2016
VIEW 13 EXCERPTS
CITES RESULTS, METHODS & BACKGROUND
HIGHLY INFLUENCED

Real-World Sustained Virologic Response Rates of Sofosbuvir-Containing Regimens in Patients Coinfected With Hepatitis C and HIV.

  • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 2016
VIEW 6 EXCERPTS
CITES RESULTS, BACKGROUND & METHODS
HIGHLY INFLUENCED

FILTER CITATIONS BY YEAR

2012
2019

CITATION STATISTICS

  • 38 Highly Influenced Citations

  • Averaged 42 Citations per year from 2017 through 2019

References

Publications referenced by this paper.
SHOWING 1-10 OF 16 REFERENCES

OlysioTM (simeprevir) full prescribing information

Janssen Products
  • https://www.olysio.com/shared/product/olysio/ prescribing-information.pdf (accessed July
  • 2014

Similar Papers

Loading similar papers…